Founded Year

1973

Stage

Corporate Minority - P2P | IPO

Market Cap

96.29B

Stock Price

78.96

Revenue

$0000 

About Sanofi

Sanofi operates as a global healthcare company in biopharmaceuticals and vaccines. The company offers products including treatments for immunology, neurology, oncology, and vaccines for infectious diseases. Sanofi also provides consumer healthcare products and is involved in clinical trial management and healthcare practices. It was founded in 1973 and is based in Paris, France.

Headquarters Location

46 Avenue de la Grande-Armée

Paris, 75017,

France

+33 (0)1 53 77 40 00

Loading...

Loading...

Sanofi Patents

Sanofi has filed 3705 patents.

The 3 most popular patent topics include:

  • drug delivery devices
  • medical equipment
  • dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/1/2018

4/8/2025

Medical equipment, Drug delivery devices, Biodegradable plastics, Copolymers, Thermoplastics

Grant

Application Date

11/1/2018

Grant Date

4/8/2025

Title

Related Topics

Medical equipment, Drug delivery devices, Biodegradable plastics, Copolymers, Thermoplastics

Status

Grant

Latest Sanofi News

Revolut hires former SocGen boss Oudea as West Europe chairman

Sep 5, 2025

CEO of France's Societe Generale, as chairman of its Western Europe hub in Paris, as it prepares to apply for a banking licence in the country. The hire underscores Revolut's aggressive expansion, as it enlists a heavyweight of France's corporate establishment. The former SocGen chief, who also chairs pharmaceuticals giant Sanofi, adds clout as the fast-growing challenger bank seeks to scale its services and credibility. Revolut announced in May that it planned to invest 1 billion euros ($1.2 billion) over the next three years expanding in France, opening a new office in Paris for its Western Europe operations. Revolut is the biggest of a number of European financial services apps founded in the past decade, with more than 60 million customers around the world but no physical branches. It is in the process of a share sale valuing the company at $75 billion, up from $45 billion in August 2024. Revolut gained a banking licence with restrictions in Britain in 2024, after a three-year process, and expects to start operating as a UK bank this year. The company has a Lithuanian banking licence, which it can use as a passport into the European Union, enabling it to sell products in the bloc. A spokesperson for Revolut previously told Reuters that having a second banking licence in the bloc would allow it to build closer relationships with regulators and offer services that are more tailored for its customers in France. Revolut is also considering buying a U.S. lender to gain a licence in the United States, according to recent media reports. A spokesperson declined to comment on the reports. Oudea is not the first banking leader to move to a challenger bank. In August, German online bank N26 announced a former member of the Bundesbank executive board, Andreas Dombret, as the new chair of its supervisory board. ($1 = 0.8542 euros) (Reporting by Elizabeth Howcroft, Editing by Louise Heavens) Related Shares Société Générale (GLE.PA) Chart Chart with 2410 data points. The chart has 1 X axis displaying Time. Data ranges from 2025-08-29 05:00:00 to 2025-09-04 15:40:00. The chart has 1 Y axis displaying values. Data ranges from 51.82 to 54.24. End of interactive chart. Sanofi (SAN.PA) Chart Chart with 2534 data points. The chart has 1 X axis displaying Time. Data ranges from 2025-08-29 05:00:00 to 2025-09-04 15:40:00. The chart has 1 Y axis displaying values. Data ranges from 76.74000000000001 to 86.11999999999999. End of interactive chart. More News

Sanofi Frequently Asked Questions (FAQ)

  • When was Sanofi founded?

    Sanofi was founded in 1973.

  • Where is Sanofi's headquarters?

    Sanofi's headquarters is located at 46 Avenue de la Grande-Armée, Paris.

  • What is Sanofi's latest funding round?

    Sanofi's latest funding round is Corporate Minority - P2P.

  • Who are the investors of Sanofi?

    Investors of Sanofi include Blackstone.

  • Who are Sanofi's competitors?

    Competitors of Sanofi include Medicines for Malaria Venture, Roivant, AbbVie, Johnson & Johnson Innovative Medicine, AstraZeneca and 7 more.

Loading...

Compare Sanofi to Competitors

S
Sumitomo Pharma

Sumitomo Pharma is a biopharmaceutical company focused on developing therapeutic and scientific breakthroughs. The company's main offerings include the development of novel cancer therapeutics and a robust pipeline of treatments aimed at addressing unmet clinical needs in oncology. Sumitomo Pharma was formerly known as Sumitomo Dainippon Pharma. It was founded in 1897 and is based in Osaka, Japan.

LifeArc Logo
LifeArc

LifeArc operates as a self-financing medical research charity. The organization specializes in drug discovery, diagnostics development, antibody humanization, and intellectual property management, aiming to lab-based scientific discoveries into diagnostics, treatments, and cures. LifeArc collaborates with various sectors including the pharmaceutical industry, biotechnology sector, and academic institutions to develop and commercialize medical research. LifeArc was formerly known as MRC Technology. It was founded in 2000 and is based in London, United Kingdom.

B
Boehringer Ingelheim

Boehringer Ingelheim is involved in healthcare within the pharmaceutical and animal health sectors. The company conducts research and development of products for humans and animals. Boehringer Ingelheim serves the healthcare industry with an emphasis on pharmaceutical products. It was founded in 1885 and is based in Ingelheim am Rhein, Germany.

Cerba HealthCare Logo
Cerba HealthCare

Cerba HealthCare provides medical diagnostics within the healthcare sector. It offers diagnostic services including proximity biology, specialty biology, clinical trial biology, anatomical and cytological pathology, medical imaging, and preventive biology. These services are used for the diagnosis and management of diseases. It was founded in 1967 and is based in Issy-les-Moulineaux, France.

Chongqing Pharmaceutical (Group) Logo
Chongqing Pharmaceutical (Group)

Chongqing Pharmaceutical (Group) operates in China's pharmaceutical industry. The company specializes in the wholesale and retail of pharmaceutical products, playing a crucial role in the distribution and accessibility of medications across various healthcare settings. It was formerly known as Southwest Branch of China Pharmaceutical Corporation. It was founded in 1950 and is based in Yuzhong, China.

P
Pfizer

Pfizer is a biopharmaceutical company involved in the discovery, development, and manufacturing of medications and vaccines aimed at improving health outcomes. The company serves the healthcare sector with its medical solutions. It is based in Jakarta, Indonesia.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.